Skip to main content
Rosalyn Juergens, MD, Oncology, Baltimore, MD

RosalynAnneJuergensMD

Oncology Baltimore, MD

Physician

Are you Dr. Juergens?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 66 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Rosalyn Juergens, MD is an oncologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2003 - 2006
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2000 - 2003
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 2000

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2003 - 2022
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Jazz Pharmaceuticals Announces Commercial Availability in Canada of Zepzelca™ (Lurbinectedin), the First New Treatment for Stage III or Metastatic Small Cell Lung Cancer in More Than a Decade
    Jazz Pharmaceuticals Announces Commercial Availability in Canada of Zepzelca™ (Lurbinectedin), the First New Treatment for Stage III or Metastatic Small Cell Lung Cancer in More Than a DecadeNovember 30th, 2021
  • Health Canada Approves Tecentriq(atezolizumab), First New Treatment in 20 Years for Aggressive Form of Lung Cancer(1)
    Health Canada Approves Tecentriq(atezolizumab), First New Treatment in 20 Years for Aggressive Form of Lung Cancer(1)August 13th, 2019
  • Lung Cancer ‘Not One Big Disease’
    Lung Cancer ‘Not One Big Disease’March 20th, 2018
  • Join now to see all